20/20 Biolabs, Inc. (AIDX) · Peers
20/20 Biolabs against the 17 other companies here in its SEC industry, SIC 873x (the wider group: its own four-digit code has fewer than five). Each figure is the one on the company's own page; the median is the peers', and the rank is among all 18, highest first.
Measure by measure
| Measure | AIDX | Peer median | Rank |
|---|---|---|---|
| Market value | $3.33M | median $563.48M | 14 of 17 |
| P/S | 1.6× | median 4.3× | 14 of 16 |
| FCF yield | -57.7% | median -0.1% | 15 of 17 |
| Gross margin | 29.6% | median 43.2% | 6 of 10 |
| Operating margin | -162.9% | median -4.9% | 12 of 16 |
| Net margin | -243.6% | median -9.6% | 12 of 15 |
| ROE | -307.4% | median -10.2% | 12 of 15 |
| Current ratio | 2.4× | median 1.6× | 6 of 18 |
| Stock pay / revenue | 25.2% | median 3.4% | 4 of 17 |
| Share count change | 2.7% | median 1.1% | 7 of 17 |
Green where 20/20 Biolabs is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| AIDX20/20 Biolabs, Inc. | $3.33M | P/E – | – | 4.5 |
| IQVIQVIA Holdings Inc | $44.55B | P/E 32.2× | 8.6% | 6.0 |
| INCYIncyte Corporation | $22.59B | P/E 15.8× | 73.6% | 8.8 |
| MEDPMedpace Holdings, Inc. | $17.31B | P/E 35.2× | – | 7.4 |
| ULSUL Solutions Inc. | $14.74B | P/E 29.2× | 26.9% | 6.5 |
| CRLCharles River Laboratories | $14.38B | P/E – | 0.4% | 4.0 |
| ICLRIcon PLC | $13.03B | P/E 307.7× | 2.2% | 5.4 |
| NEONeogenomics Inc | $2.17B | P/E – | -10.0% | 4.7 |
| OABIOmniAb, Inc. | $679.70M | P/E – | -18.3% | 4.1 |
| NRCNational Research Corp | $447.26M | P/E 81.9× | 12.0% | 4.6 |
| ONMDOneMedNet Corp | $278.05M | P/E – | – | 3.5 |
| MXCTMaxcyte, Inc. | $133.65M | P/E – | -62.2% | 4.3 |
| BIAFbioAffinity Technologies, Inc. | $30.22M | P/E – | -505.1% | 3.5 |
| VSBCVitaspring Biomedical Co. Ltd. | $26.33M | P/E – | – | 2.9 |
| CBIHCannabis Bioscience International Holdings, Inc. | $2.33M | P/E – | – | 2.8 |
| ISPCiSpecimen Inc. | $2.31M | P/E – | – | 3.5 |
| FOXOFoxo Technologies Inc. | $182,393 | P/E – | -5.5% | 4.4 |
| ABSIAbsci Corp | – | P/E – | -220.9% | 3.3 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.